Page 42 - Access Pool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Call for UK to back patent waiver on COVID-19 vaccines Open letter tells prime minister Boris Johnson to "stand on the right side of history". Meanwhile EU is reluctant to follow the US and back vaccines waiver UK prime minister, Boris Johnson More than 400 academics, politicians, charities, and others have called on UK prime minister Boris Johnson to follow the US in backing a waiver of intellectual property rights for COVID-19 vaccines. This follows on from US president Joe Biden unexpectedly throwing his support behind a waiver – a move described by the World Health Organisation's direct...

Protesters demanding that AstraZeneca share its Covid-19 vaccine technology have held a loud demonstration outside the pharmaceutical firm’s Cambridge headquarters. A protester, who held held a sign which read “human life not profit,” chained himself to a door while others climbed on to the roof of the entryway and unfurled a banner which read “people’s vaccine not profit vaccine”. Supporters played drums during the protest organised by Global Justice Now, which is calling for the British-Swedish company to commit to sharing the technology with the World Health Organisation (WH...

Protesters demanding that AstraZeneca share its Covid-19 vaccine technology have clashed with police outside the pharmaceutical giant's headquarters. A group of mostly young activists blocked the entrance to the firm's main building in a Cambridge business park. The protestors are accusing the pharmaceutical company of profiting during the pandemic and to demand the jab is openly licensed and shared with the World Health Organisation (WHO). One protester holding a sign reading 'human life not profit', chained himself to a door while others climbed on to the roof of the entryway and unfurle...

AstraZeneca protest: Reports of arrests as police shout 'step back' in scuffle with protesters One video from the scene appears to show protesters scuffling with police 14:52, 11 MAY 2021 Updated The video will auto-play soon8Cancel Play now Sign up to our newsletter for daily updates and breaking newsInvalid EmailSomething went wrong, please try again later. Sign up here! When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice. Thank you for subscribingWe have more newslettersShow meSee ourpr...

Disclosure statement In 2017-2020, Joel Lexchin received payments for being on a panel at the American Diabetes Association, for talks at the Toronto Reference Library, for writing a brief in an action for side effects of a drug for Michael F. Smith, Lawyer and a second brief on the role of promotion in generating prescriptions for Goodmans LLP and from the Canadian Institutes of Health Research for presenting at a workshop on conflict-of-interest in clinical practice guidelines. He is currently a member of research groups that are receiving money from the Canadian Institutes of Health Resear...